Page 7 - Clinical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunity-centric biotech firm lands $60m in Series A funding Immunai has secured a total of $80m in funding to develop and promote its efforts to harness machine learning to fuel advancement of novel immunotherapies. New York City- and Tel Aviv-based biotechnology firm Immunai has secured another $60m in Series A funding, bringing the company’s total funding landed to date to more than $80m. Immunai’s technology integrates multi-omic single-cell analytics and machine learning (ML) to identify novel immunological insights, in the hopes of discovering and develop...

A peer-reviewed study indicates that the company’s antigen test could be more selective in detecting contagious COVID-19 patients than PCR testing.

The collaboration between the Jameel Clinic and pharma firm will harness artificial intelligence and machine learning in developing health solutions. The Abdul Latif Jameel Clinic for Machine Learning in Health at the Massachusetts Institute of Technology (MIT) is forging a long-term partnership with Sanofi. The research teams will work together to develop and apply artificial (AI) and machine learning (ML) technology to advance drug discovery, development of treatments and other projects. Outsourcing-Pharma (OSP) recently discussed the partnership with Ignacio Fue...

The federal agency continues to keep researchers, pharma firms and citizens apprised of current happenings and research related to the virus and pandemic.

Calyx spins off medical imaging, eClinical solutions firm Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward. Calyx—a UK-based company offering medical imaging, eClinical and regulatory services to clinical research clients—has shed the name Parexel Informatics in favor of its new moniker. After this strategic separation, the company will continue its work pursuing innovative technology intended to accelerate the discovery and development of new treatments. With ...